We Improve the Discoverability of Press Releases
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.
Latest News
Hong Kong Jewellery Show Unveils Global Designs & Tech Innovations
about 3 hours ago

Aliens Cast Reunites for Epic Fan Event in California
about 4 hours ago

GridAI Partners with Amp Z to Power Massive AI Data Center Expansion
about 5 hours ago

HeartBeam Upgraded to Buy as FDA-Cleared ECG System Nears Market
about 5 hours ago

HR News
HR.com Announces 2026 Leadership Development Award Winners
about 12 hours ago
Global Hiring Accelerates Amid AI Reshaping and Engagement Strain in 2026
about 17 hours ago
Fractional HR: Texas's Answer to Growth & Compliance Risks
7 days ago
HR.com Honors Top CHROs and Women Leaders in 2026 Awards
7 days ago
Galaxy Payroll Renews 5-Year Strategic Deal with Nike Macau
8 days ago
Business News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 7 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 7 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 3 months
ANDRITZ CEO's Contract Extended to 2032, Securing Leadership for Green Tech Push
about 1 hour ago
PATRIZIA Reports Strong 2025 Results: EBITDA Up 35%, Dividend Increased
about 1 hour ago
Crypto News
NxGen Launches $CAND Token on Solana, Merging Candy Brands with Blockchain Rewards
1 day ago
Greenlane Unveils Berachain Crypto Strategy in New Investor Overview
1 day ago
Greenlane Deploys 50M BERA Tokens, Appoints New CEO for Crypto Treasury Push
1 day ago
BLAQclouds Launches ApolloNFT & theAlley V2 to Revolutionize Creator Economy
2 days ago
Datavault AI Announces Josh Gibson Coin Dividend for Shareholders
5 days ago
Health News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 7 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 7 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 3 months
REMSleep Navigates Founder's Passing, Appoints New CEO for DeltaWave Launch
about 4 hours ago
HeartBeam Partners with ClearCardio to Revolutionize Remote Cardiac Monitoring
about 4 hours ago
Technology News
ANDRITZ CEO's Contract Extended to 2032, Securing Leadership for Green Tech Push
about 1 hour ago
HeartBeam Partners with ClearCardio to Revolutionize Remote Cardiac Monitoring
about 4 hours ago
GridAI Partners with Amp Z to Power Massive AI Data Center Expansion
about 5 hours ago
JCB & Resona Launch World's First Project to Commercialize Hands-Free UWB Payments
about 5 hours ago
Uniserve Advances Vancouver Data Centre, Targets Canadian SMB Digital Infrastructure Leadership
about 6 hours ago
Events & Conferences
Hong Kong Jewellery Show Unveils Global Designs & Tech Innovations
about 3 hours ago
Aliens Cast Reunites for Epic Fan Event in California
about 4 hours ago
GBH Host Edgar B. Herwick III to Present 58th Annual Bell Ringer Awards
about 11 hours ago
Four Impact Companies Pitch Live on TV with Audience Q&A and Voting
about 17 hours ago
Human Rights Leaders Unite in DC to Build Practical Solutions for Dignity
about 17 hours ago






